6,7-Bis(2-chloroethoxy)-N-(3-ethynylphenyl)-4-quinazolinamine is an intermediate in the preparation of (bis(morpholinoalkoxy))(phenylamino)quinazolines derivatives as epidermal growth factor receptor (EGFR) inhibitors with anti proliferative activity against tumor cells.
